-$0.11 Earnings Per Share Expected for Motus GI Holdings, Inc. (NASDAQ:MOTS) This Quarter

Equities research analysts predict that Motus GI Holdings, Inc. (NASDAQ:MOTS) will announce ($0.11) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Motus GI’s earnings. The lowest EPS estimate is ($0.12) and the highest is ($0.10). Motus GI reported earnings of ($0.13) per share in the same quarter last year, which suggests a positive year over year growth rate of 15.4%. The business is expected to report its next earnings results on Thursday, November 11th.

On average, analysts expect that Motus GI will report full-year earnings of ($0.47) per share for the current year, with EPS estimates ranging from ($0.54) to ($0.41). For the next fiscal year, analysts anticipate that the business will post earnings of ($0.42) per share, with EPS estimates ranging from ($0.46) to ($0.39). Zacks Investment Research’s EPS calculations are an average based on a survey of research analysts that follow Motus GI.

Motus GI (NASDAQ:MOTS) last released its earnings results on Thursday, August 12th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.11) by $0.01. The firm had revenue of $0.10 million for the quarter, compared to analyst estimates of $0.08 million. Motus GI had a negative return on equity of 73.19% and a negative net margin of 8,058.18%.

Several equities analysts recently commented on MOTS shares. Zacks Investment Research downgraded Motus GI from a “buy” rating to a “hold” rating in a research report on Friday, July 16th. Piper Sandler lowered their target price on Motus GI from $2.50 to $1.50 and set an “overweight” rating for the company in a research note on Thursday, August 12th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $2.00 price objective on shares of Motus GI in a research note on Thursday, September 9th.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Northern Trust Corp lifted its stake in shares of Motus GI by 74.4% in the 1st quarter. Northern Trust Corp now owns 51,529 shares of the company’s stock valued at $62,000 after acquiring an additional 21,991 shares during the last quarter. Neuberger Berman Group LLC acquired a new stake in shares of Motus GI in the 1st quarter valued at about $123,000. Renaissance Technologies LLC lifted its position in Motus GI by 5.1% in the 1st quarter. Renaissance Technologies LLC now owns 530,684 shares of the company’s stock valued at $642,000 after acquiring an additional 25,800 shares in the last quarter. Steel Peak Wealth Management LLC bought a new position in shares of Motus GI during the 1st quarter worth approximately $26,000. Finally, Millennium Management LLC bought a new position in shares of Motus GI during the 1st quarter worth approximately $104,000. Hedge funds and other institutional investors own 15.18% of the company’s stock.

Shares of MOTS stock traded down $0.00 during mid-day trading on Friday, reaching $0.76. The stock had a trading volume of 898 shares, compared to its average volume of 2,735,066. The firm has a market cap of $36.42 million, a PE ratio of -1.26 and a beta of 2.58. Motus GI has a one year low of $0.68 and a one year high of $2.74. The firm’s 50 day simple moving average is $0.86 and its 200 day simple moving average is $1.05.

Motus GI Company Profile

Motus GI Holdings, Inc is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Recommended Story: What is the Quick Ratio?

Get a free copy of the Zacks research report on Motus GI (MOTS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.